11. B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn. Issue 6 (June 2013) Authors: Herishanu, Yair; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 54:Issue 6(2013:Jun.) Page Start: 1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Basophils go wild when mosquitoes bite CLL. Issue 10 (2nd October 2016) Authors: Wendtner, Clemens-Martin; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Bendamustine associated immune suppression and infections during therapy of hematological malignancies. Issue 3 (3rd March 2016) Authors: Gafter-Gvili, Anat; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 57:Issue 3(2016:Mar.) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Bone lesions in hairy cell leukemia: Diagnosis and treatment. (19th August 2020) Authors: Robak, Pawel; Jesionek‐Kupnicka, Dorota; Kupnicki, Piotr; Polliack, Aaron; Robak, Tadeusz Journal: European journal of haematology Issue: Volume 105:Number 6(2020) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Bone marrow fibrosis: a prognostic scar in hematological malignancies. Issue 11 (November 2013) Authors: Tadmor, Tamar; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting. (May 2021) Authors: Bettelli, Stefania; Marcheselli, Raffaella; Pozzi, Samantha; Marcheselli, Luigi; Papotti, Robel; Forti, Elisa; Cox, M. Christina Christina; Di Napoli, Arianna; Tadmor, Tamar; Mansueto, Giovanna R.; Musto, Pellegrino; Flenghi, Leonardo; Quintini, Martina; Galimberti, Sara; Lalinga, Vittoria; Donat... Journal: Leukemia research Issue: Volume 104(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Chemoimmunotherapy with fludarabine, cytoxan and rituximab regimen: to use, not to use, or give it as "FCR-LITE"?. Issue 4 (April 2014) Authors: Tadmor, Tamar; Mclaughlin, Peter; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 55:Issue 4(2014:Apr.) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Chronic lymphocytic leukemia is becoming more complex: how to define complex karyotype?. Issue 3 (4th March 2018) Authors: Kreinitz, Natalia; Polliack, Aaron; Tadmor, Tamar Journal: Leukemia & lymphoma Issue: Volume 59:Issue 3(2018) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyond. Issue 4 (21st March 2021) Authors: Harrop, Sean; Polliack, Aaron; Tam, Constantine S. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 4(2021) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. CLL and CML sometimes meet and circulate together. Issue 6 (12th May 2019) Authors: Matutes, Estella; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 60:Issue 6(2019) Page Start: 1352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗